|
How many volunteers were present at the Congress? : |
Over 1000 participants |
|
Delegates from which countries presented in the congress? : |
Delegates from different countries of Asia including Iran, Turkey, Jordan, Saudi Arabia, Lebanon, China, Japan, India … and also participants form he EU countries (France, UK, Germany, Netherlands, Italy, Spain, Belgium, Norway, …) and delegates from other countries such as USA, Brazil, Venezuela, Argentina, Egypt,… were attended at the conference. |
|
Were the delegates of any other organizations present in the congress? : |
Yes |
|
If yes, please write the names of the organizations in the box : |
Shahid Beheshti University of Medical Sciences, Tabriz University of Medical Sciences, Mashhad University of Medical Sciences. |
|
What were the responses to your talking points? Were specific questions or concerns raised? : |
My lecture was held in parallel session on “Mechanisms’’. Once my presentation finished some audiences praised my lecture and asked their questions about the endogenous LINE 1 and post modification effects of arsenic of L1 retrotranspositions events. After my lecture, Professor Franco M. Buonaguro from Napoli, Italy suggested me to collaborate about the cancerous effects of arsenic in volcanic area of Italy on Leukemia patients. |
|
If you met staff members, please list their full names & positions. : |
I had a meeting with Christopher P. Wild, Director of IARC2016 conference, International Agency for Research on Cancer, Lyon, France about how we can collaborate with IARC on skin neoplasms.
I also met Pro.Franco M. Buonaguro, Director of the Molecular Biology and Viral Oncology Unit at the Natl Cancer Institute “Fond Pascale “ Napoli-Italy and the Editor in Chief of Infectious agents and cancer journal. We talked how we can develop and expand our relationships on arsenic research in volcanic area of Italy that has more incidence of leukemia. |
|
Please inform us if there are any follow up actions we need to talk with the members of the congress : |
From the feedback I have received both at the meeting and in the subsequent weeks, I believe the conference was an outstanding success. As IARC stated the conference was the largest ever meeting organized by IARC and they are now actively considering how to maintain this important network of cancer scientists involved, in one way or another, with a shared set of research objectives. In this respect, they may communicate with me further in the weeks ahead. |
|
Your experiences about the travel processes(Providing ticket, accommodation,...) : |
I did not face any difficulty in travel and accommodation in Lyon since I reserved all these in advance. |
|
Please give a briefing of your own observations and outcomes of the congress: : |
This was scientific conference to celebrate the 50th anniversary of the International Agency for Research on Cancer
The major themes of this landmark conference were structured around the core activities of IARC and cover global cancer occurrence, etiology, and prevention as well as implementation of prevention and early detection. The conference featured keynote lectures from eminent international cancer researchers, as well as smaller themed workshops and symposia for which contributed papers and poster presentations were invited. The programme also included three debates on controversial issues together with “big picture” lectures linking cancer, science, and society. |